Subarachnoid Hemorrhage Withdrawn Phase Trials for Esmolol (DB00187)

Also known as: Subarachnoid bleeding / Subarachnoid haemorrhage / Subarachnoid hemorrhage NOS / Subarachnoid haemorrhage NOS / Haemorrhage subarachnoid / Hemorrhage subarachnoid

IndicationStatusPhase
DBCOND0029809 (Subarachnoid Hemorrhage)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01232400Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid HemorrhageTreatment